- About Us
- Advisory Board
- Editorial
- Contact Us
- Advertise
- Contact MJH LS
- Do Not Sell My Information
- Terms and Conditions
- Privacy
© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.
Top Medical News
Episode 64: Genetics, Advocacy, and Big Data in ALS
May 20, 2022
By Matt Hoffman
Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Matthew B. Harms, MD.
Diazepam Nasal Spray Significantly Extends Time Between Seizure Clusters
May 19, 2022
By Marco Meglio
At the end of the 12-month treatment period, interseizure cluster intervals increased from 14.8 days in the first period to 35.8 days in the final 90-day stretch.
Full Dataset Shows Additional Benefit for SMA With Higher Dose Nusinersen
May 19, 2022
By Marco Meglio
A PK/PD model indicated that a higher concentration of nusinersen may predict an additional 5-point increase in CHOP-INTEND score beyond that observed with the approved 12-mg dose.
Serum Neurofilament Light Poses as Critical Biomarker During Ataxic, Preataxic Stages of Spinocerebellar Ataxias
May 18, 2022
By Marco Meglio
In preataxia individuals, serum neurofilament levels increased with proximity to predicted ataxia onset, with significant elevations already present 5 years before onset.
Connecting ALS: How New Drug Coverage Decisions Are Made
May 18, 2022
By Jeremy Holden
In this episode of Connecting ALS, Dave R. Zook, JD, an advisor with expertise in federal regulatory policy, speaks to the process of making drug coverage decisions for newly approved therapies.
Featured
Latest Videos
Most Recent
